Serum B-cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survival-Reference-Cited by-同舟云学术

Serum B-cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survival

Published:2012-07-18 Issue:6 Volume:158 Page:727-738
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Sanchez Eric¹,Li Mingjie¹,Kitto Alex¹,Li Jennifer¹,Wang Cathy S.¹,Kirk Dylan T.¹,Yellin Ori¹,Nichols Cydney M.¹,Dreyer Marissa P.¹,Ahles Cameryn P.¹,Robinson Austin²,Madden Erik²,Waterman Gabriel N.³,Swift Regina A.⁴,Bonavida Benjamin⁵,Boccia Ralph⁶,Vescio Robert A.⁷,Crowley John⁸,Chen Haiming¹,Berenson James R.

Affiliation:

1. Institute for Myeloma & Bone Cancer Research; West Hollywood; CA; USA

2. David Geffen School of Medicine; University of California; Los Angeles; CA; USA

3. Keck School of Medicine; University of Southern California; Los Angeles; CA; USA

4. James R. Berenson, MD, Inc; West Hollywood; CA; USA

5. Department of Microbiology; Immunology and Molecular Genetics; Geffen School of Medicine; University of California; Los Angeles; CA; USA

6. Center for Cancer and Blood Disorders; Bethesda; MD; USA

7. Cedars-Sinai Medical Center; Los Angeles; CA; USA

8. Cancer Research and Biostatics; Seattle; WA; USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2012.09241.x/fullpdf

Reference48 articles.

1. Graft-verus-tumour response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptor;Bellucci;Blood,2005

2. Animal models of multiple myeloma and their utility in drug discovery;Campbell;Current Protocols in Pharmacology,2008

3. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases;Cheema;Arthritis Rheumatology,2001

4. Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL;Chiu;Blood,2007

5. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA;Day;Biochemistry,2005

Cited by 222 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bispecific antibodies in the treatment of multiple myeloma;Blood Cancer Journal;2024-09-12

2. Current status of BAFF targeting immunotherapy in B-cell neoplasm;International Journal of Clinical Oncology;2024-09-02

3. Serum B-Cell Maturation Antigen Reflects Disease Status in a Patient Who Developed Nonsecretory Multiple Myeloma: A Case Report;Case Reports in Oncology;2024-07-12

4. Just scratching the surface: novel treatment approaches for multiple myeloma targeting cell membrane proteins;Nature Reviews Clinical Oncology;2024-07-03

5. Bispecific Antibodies for Multiple Myeloma: Recent Advancements and Strategies for Increasing Their Efficacy;Frontiers in Bioscience-Landmark;2024-06-17